Bahl & Gaynor Inc Blue Water Vaccines Inc. Transaction History
Bahl & Gaynor Inc
- $17.9 Billion
- Q2 2024
A detailed history of Bahl & Gaynor Inc transactions in Blue Water Vaccines Inc. stock. As of the latest transaction made, Bahl & Gaynor Inc holds 34,710 shares of BWV stock, worth $5,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,710
Previous 34,710
-0.0%
Holding current value
$5,900
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BWV
# of Institutions
21Shares Held
2.95MCall Options Held
0Put Options Held
0-
American Financial Group Inc1.44MShares$244,9570.1% of portfolio
-
Cetera Investment Advisers Schaumburg, IL320KShares$54,4000.0% of portfolio
-
Zurcher Kantonalbank (Zurich Cantonalbank) Zurich, V8306KShares$52,0330.0% of portfolio
-
Bank Of America Corp Charlotte, NC125KShares$21,2720.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA114KShares$19,3250.0% of portfolio
About Blue Water Vaccines Inc.
- Ticker BWV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,744,900
- Market Cap $2.34M
- Description
- Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical de...